Polakis, Paul
Genentech, Inc,
United States
2024 Rank: 33939
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 608 out of 208384 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33939 | 39241 |
| Total Cites | 562 | 571 |
| H-index | 12 | 12 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 105 | 105 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 110 | 110 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 238 | 240 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 459 | 463 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.23 |
| Self-Citation Percentage |
1.58%
|
|
Polakis, Paul
Genentech, Inc,
United States
2023 Rank: 28699
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 580 out of 204091 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28699 | 32872 |
| Total Cites | 630 | 648 |
| H-index | 11 | 11 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 135 | 135 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 141 | 141 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 286 | 286 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 501 | 510 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.27 |
| Self-Citation Percentage |
2.78%
|
|
Polakis, Paul
Genentech Incorporated,
United States
2022 Rank: 12386
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 309 out of 201173 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 12386 | 14260 |
| Total Cites | 749 | 772 |
| H-index | 14 | 14 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 201 | 202 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 209 | 210 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 400 | 401 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 594 | 602 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.28 |
| Self-Citation Percentage |
2.98%
|
|
Polakis, Paul
Genentech Incorporated,
United States
2021 Rank: 10209
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Biochemistry & Molecular Biology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 242 out of 189264 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10209 | 11971 |
| Total Cites | 1240 | 1287 |
| H-index | 19 | 19 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 327 | 328 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 335 | 336 |
| Number of Single+First+Last Authored Papers | 63 | 63 |
| Total Cites to Single+First+Last Authored Papers | 641 | 643 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 966 | 983 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.31 |
| Self-Citation Percentage |
3.65%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.